版本:
中国

BRIEF-Aimmune Therapeutics Q4 loss per share $0.55

March 15 Aimmune Therapeutics Inc

* Aimmune Therapeutics announces fourth quarter and full year 2016 financial results

* Sees 2017 capital expenditures approximately $5 million

* Qtrly loss per share $0.55

* Sees 2017 research and development expenses $95 million - $105 million

* Q4 earnings per share view $-0.47 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐